Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
SYH2043
/
CSPC Pharma
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|||
|||||||
SYH2043
/
CSPC Pharma
New P1 trial, Metastases:
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
(clinicaltrials.gov) - Feb 15, 2023
P1
, N=367, Not yet recruiting,
Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd.